Posts Tagged ‘food’

At $290,000 test-tube burger is a taste of what's to come

Monday, February 20th, 2012

Would you like fries with that? British celebrity chef Heston Blumenthal could be flipping test-tube burgers.

LURKING in a petri dish in a laboratory in the Netherlands is an unlikely contender for the future of food. The yellow-pink sliver is state-of-the-art in lab-grown meat and a milestone on the path to the world's first burger made from stem cells.

Dr Mark Post, the head of physiology at Maastricht University, plans to unveil a complete burger – produced at a cost of more than $290,000 – this October.

He hopes Heston Blumenthal, the chef and owner of the three Michelin-starred Fat Duck restaurant in Berkshire, southern England, will cook the offering for a celebrity taster.

Advertisement: Story continues below

A new meaning to instant meals … food in a test-tube.

The project, funded by a wealthy, anonymous, individual, aims to slash the number of cattle farmed for food and reduce one of the major contributors to greenhouse gas emissions.

''Meat demand is going to double in the next 40 years and right now we are using 70 per cent of all our agricultural capacity to grow meat through livestock,'' Dr Post said.

''You can easily calculate that we need alternatives. If you don't do anything meat will become a luxury food and be very, very expensive.''

Livestock contribute to global warming through unchecked releases of methane, a gas 20 times more potent than carbon dioxide.

At the American Association for the Advancement of Science meeting in Vancouver, Dr Post said the burger would be a ''proof of concept'' to demonstrate that ''with in-vitro methods, out of stem cells we can make a product that looks like and feels and hopefully tastes like meat.''

Dr Post is focusing on making beef burgers from stem cells because cows are among the least efficient animals at converting the food they eat into food for humans.

Dr Post and his team have so far grown thin sheets of cow muscle measuring 3 centimetres long, 1.5 centimetres wide and half a millimetre thick. To make a burger will take 3000 pieces of muscle and a few hundred pieces of fatty tissue, that will be minced together and pressed into a patty.

Each piece of muscle is made by extracting stem cells from cow muscle tissue and growing them in containers. The cells are grown in a culture medium containing foetal calf serum, which contains scores of nutrients the cells need to grow.

Guardian News & Media

Read the original here:
At $290,000 test-tube burger is a taste of what's to come

Few rheumatoid arthritis clinical trials compare drugs: study

Saturday, February 18th, 2012

NEW YORK (Reuters Health) – To test whether a new drug is an improvement over existing treatments, the ideal clinical trial would compare the medications head to head, but few trials of rheumatoid arthritis treatments happen that way, according to a new study.

Instead, researchers found that for certain new rheumatoid arthritis medications, subjects in the comparison groups were often assigned to continue taking a drug that didn't help them or to take a fake drug called a placebo — in both cases effectively depriving those patients of treatment for their disease.

“Of course it's easier to compare to a placebo than an active treatment but in no way can it justify exposing patients to irreversible morbidity,” said Dr. Candice Estellat at the French national medical research institute, INSERM, who led the study.

Her concern is that if studies don't compare a new drug to other effective ones, people's conditions will persist or even worsen throughout the study.

Additionally, without so-called head-to-head trials, doctors will have little evidence to go on to determine whether one treatment is better than another, Estellat said.

Rheumatoid arthritis is an autoimmune disease that causes inflammation and damage to joints.

About 1.5 million adults have the painful disorder, and they typically require lifelong treatment with physical therapy or medications, such as methotrexate.

The newest forms of rheumatoid arthritis medications to become available are called biologic disease-modifying antirheumatic drugs (DMARDs).

These include the brand-name medications Enbrel and Humira. They come in the form of an injection, and cost around $15,000 per year.

Estellat and a colleague gathered information on all clinical trials of biologic DMARDs registered with the U.S. government's clinicaltrials.gov website and that were ongoing between 2002 and 2009.

She said they decided to do the study after hearing from specialists about the lack studies comparing these new drugs against other biologic DMARDs.

Of the 91 trials they identified, just five studies compared one biologic medication to another.

“Unfortunately we were not surprised as it confirms rheumatologists' feeling(s),” Estellat said.

The remaining trials will not provide doctors and patients with information for making evidence-based decisions, she and her coauthor write in the Archives of Internal Medicine.

“There (are) plenty of studies to show that A is better than placebo, B is better than placebo, C is better than placebo but so few to know which one is the best between A, B or C,” Estellat told Reuters Health by email.

Not only are placebo-compared experiments less useful in understanding how well a drug works compared to others, but, the report points out, they may violate international ethical research standards and specific guidelines from the American College of Rheumatology if people are not given treatment for a serious condition like rheumatoid arthritis.

The 91 trials included 102 comparisons of a biologic medication against something else — in most cases that something else was a placebo or a treatment previously shown not to work for them.

“Despite recommendations to give biologic treatments to patients with an inadequate response to conventional treatment, 9,879 patients were or will be randomized to control arms to receive no treatment or their previous ineffective treatment,” Estellat said.

Studies on humans have to go through ethical scrutiny by independent bodies called institutional review boards, and in the U.S. they must also be approved by the Food and Drug Administration.

A spokesperson for the pharmaceutical trade group, PhRMA, wrote in an email to Reuters Health that “much of that decision-making is done under the guidance of FDA, whose experts are able to work with companies to evaluate the pros and cons of different types of trials.”

Dr. Steven Pearson, the president of the Institute for Clinical and Economic Review in Boston, explained the possible reasons for not using head-to-head trials for certain drugs in an editorial accompanying Estellat's study.

He agreed that using placebos is a less desirable trial design to ultimately help physicians determine which medication they should prescribe for their patients, but said it's a trade-off for making an experiment less difficult.

“For one, having an active agent against a comparator would require many more patients,” he told Reuters Health.

“In order to be able to get clear signals of the safety and effectiveness of new agents it's going to be easiest to compare it to a placebo, in terms of costs and duration,” Pearson added.

To be most useful to patients and physicians, clinical trials need to compare one drug to another, and Pearson said that companies, regulators and researchers should think of creative ways to do so without having the studies become prohibitively expensive or unwieldy.

“I think the study is helpful to (the Food and Drug Administration) and others to take stock and see if there are other innovative study designs and approaches that allow more head-to-head trials,” Pearson said.

Estellat said that people involved in clinical studies “have to imagine original designs to conciliate ethics and scientific requirements.”

SOURCE: http://bit.ly/yh1orf Archives of Internal Medicine, February 13, 2012.

More here:
Few rheumatoid arthritis clinical trials compare drugs: study

The Food Allergy & Anaphylaxis Network Funds Study Focusing on Anaphylaxis

Thursday, February 16th, 2012

FAIRFAX, Va.–(BUSINESS WIRE)–

Food allergy reactions are impossible to predict – one reaction may be mild while another equates to anaphylaxis, a serious allergic reaction that is rapid in onset and may cause death. In an effort to improve our understanding of anaphylaxis, the Food Allergy & Anaphylaxis Network’s (FAAN™) Research Grant Program has awarded $260,000 to be paid over a two year period to a scientist whose study seeks to answer several key questions about this life-threatening reaction.

Simon G.A. Brown, M.D., of the Centre for Clinical Research in Emergency Medicine, Western Australia Institute for Medical Research, has recently begun his two-year study, “Leukocyte signaling during human anaphylaxis.” By studying how the immune system is activated during anaphylaxis, Brown hopes to impact the design of future treatments and preventative strategies for food allergy, which is the leading cause of anaphylaxis outside the hospital setting.

“Food allergy among children is on the rise, so it is critical for us to gain knowledge about the mechanisms of anaphylaxis in order to try to develop a way to treat it effectively,” said FAAN CEO Maria L. Acebal. “Dr. Brown’s research will attempt to get us closer to these answers, a life-saving endeavor so critical to families living with food allergies.”

Brown’s team will use a genome-wide approach to identify factors that contribute to the severity and clinical symptoms of anaphylaxis. By analyzing blood samples from patients who were treated in the emergency department over time, Brown hopes to define the molecular pathways that are activated during anaphylaxis, and more importantly the sequence in which this occurs. FAAN previously funded Brown’s 2006 study, “Mediators of human anaphylaxis.”

“In our previous FAAN study we defined which cytokines –messenger proteins produced by cells– are involved in human anaphylaxis,” said Dr Brown. “We then formed a hypothesis that white cells in the blood may be a key part of the early inflammatory process that converts mild reactions into severe ones.”

“By studying the genes that are activated very early during a severe anaphylactic reaction (on arrival in the Emergency Department), measuring how the activation of other genes proceeds over the next few hours, and correlating this with the concentrations of inflammatory substances in the blood, we may be able to identify this key link,” he said.

FAAN’s competitive Research Grant Program has awarded more than $5 million since 2004. The program is funded by FAAN members and individual donors. For more information about FAAN, visit www.foodallergy.org.

About FAAN

Founded in 1991, the Food Allergy & Anaphylaxis Network (FAAN) is the world leader in information about food allergy, a potentially life-threatening medical condition that afflicts as many as 15 million Americans, including almost 6 million children. A nonprofit organization based in Fairfax, Va., FAAN has approximately 22,000 members in the U.S., Canada, and 58 other countries. It is dedicated to increasing public awareness of food allergy and its consequences, to educating people about the condition, and to advancing research on behalf of all those affected by it. FAAN provides information and educational resources about food allergy to patients, their families, schools, health professionals, pharmaceutical companies, the food industry, and government officials. To become a member or for more information, please visit FAAN at www.foodallergy.org.

Excerpt from:
The Food Allergy & Anaphylaxis Network Funds Study Focusing on Anaphylaxis

How to Fight Type 2 Diabetes

Tuesday, February 14th, 2012

You might not know this from listening to the American Diabetes Association or Paula Deen, the new face of the disease, but the first line of defense against type 2 diabetes is weight loss.

So many comments came in to my post on Paula Deen's diabetes announcement, “Weighing in on Paula Deen,” that I thought it was worth revisiting a related column. The question came from a reader:

I have been diagnosed with type 2 diabetes and am very confused about insulin resistance, and what carbohydrates I can and cannot eat. So much of what I read is contradictory.

The first line of defense against type 2 diabetes is weight loss, but you would never know it from listening to Paula Deen, the celebrity Southern cook who recently announced that she has this disease, or even to the American Diabetes Association.

Having diabetes is no joke. It is a leading cause of blindness, kidney failure, leg and foot amputations, and premature death.

The disease comes in two forms — type 1 and type 2 — but type 2 accounts for 95 percent of cases. In both, levels of blood sugar are too high as a result of problems with insulin, a hormone that enables the body to use blood sugar for energy. But the reasons differ.

Type 1 is an autoimmune disease. It causes the pancreas to stop making insulin or not make enough. Type 1 is not yet preventable and requires insulin treatment. In type 2, insulin may be available, but body tissues resist its use.

Being overweight is the key factor in type 2. Most people can prevent it by not gaining weight. And most people with the type 2 disease can eliminate symptoms by losing some weight. Genetics is certainly a factor — many overweight people never develop the disease — but 85 percent or more of people diagnosed with type 2 diabetes are overweight or obese.

In genetically predisposed people, being overweight causes insulin resistance. Metabolism does not handle excess calories very well, and this means calories from any source, not just carbohydrates.

FAST FOOD, SOFT DRINKS

Children and adults who habitually consume fast food as well as soft drinks tend to take in more calories and weigh more and are more likely to develop symptoms than people who eat healthier diets and are more active.

This makes healthy eating and physical activity the most important approaches. The vast majority of overweight people at risk of type 2 diabetes can prevent symptoms by losing a few percent of their body weight and doing a couple of hours a week of moderate — not necessarily vigorous — physical activity. The same works for treatment. Some people will still need medications, but the drugs work better with diet and physical activity.

As the Centers for Disease Control and Prevention puts it: “[A]ll diabetes-care programs should make healthy weight a priority.”

Dietary advice for type 2 diabetes is the same as advice for everyone else: Eat a wide variety of relatively unprocessed foods, especially vegetables, fruits, and whole grains, and don't consume too much junk food or too many sugary beverages.

Scientists may argue endlessly about the relative importance of calories, sugars, and refined carbohydrates in the diets of people with type 2 diabetes, but everyone agrees that eating less of all three would help resolve symptoms.

Why isn't weight loss better recognized as a treatment strategy? Paula Deen's announcement said nothing about losing weight.

The ADA does talk about weight loss on its website, but you must search hard through several complicated screens before you find, “Losing just a few pounds through exercise and eating well can help with your diabetes control and can reduce your risk for other health problems.”

PHARMACEUTICALS

I can't help wondering if the lack of prominence given to weight loss might have something to do with the influence of pharmaceutical companies.

A few years ago, I gave a talk on the importance of weight loss in control of type 2 diabetes at an ADA annual meeting. Although many conference talks dealt with drug treatment, mine was the only one on diet — except for a session on sugars sponsored by Coca-Cola.

The exhibit hall was packed with drug company representatives dispensing free pens, writing pads, books, lab coats and stethoscopes — all with corporate logos.

The influence of drug companies on diabetes advice is worth attention. Deen represents a drug that costs hundreds of dollars a month. Drug companies give the ADA millions every year.

Eating less and being active make no money for anyone (unless people can be induced to join commercial weight-loss programs).

Losing weight is a losing battle for many people. It's hard to lose weight in today's “eat more” food marketing environment.

TEACHABLE MOMENT

But a diagnosis of type 2 diabetes should be a teachable moment. Shouldn't the ADA more strongly urge people with the disease to eat less, eat better, and move more, and help everyone find ways to cope with “eat more” messages?

The health and economic costs of type 2 diabetes, and its preventability, are reason enough to demand changes in the food environment. The ADA should be working hard to make it easier for everyone to eat more healthfully, be more active, and avoid the need for a lifetime of diabetes medications.

Image: upthebannerShutterstock.

This post also appears on Food Politics, an Atlantic partner site.

Read more here:
How to Fight Type 2 Diabetes

Does Arthritis Raise Kids' Cancer Risk?

Tuesday, February 14th, 2012

Children with juvenile idiopathic arthritis (JIA), the most common form of childhood arthritis, may be at higher risk of developing cancer than children who do not have the condition, according to a new study published in the journal Arthritis & Rheumatism.

Researchers identified 7,812 children with JIA and compared them with thousands of children not affected by JIA and found that the arthritic children developed about four times as many new growths considered likely to be cancerous as children who did not have arthritis. They followed the children for about 18 months.

“Based on the data, it appears that being diagnosed with JIA increases the likelihood of developing malignancies,” said Dr. Timothy Beukelman, the study's lead author and an associate professor of pediatrics at the University of Alabama at Birmingham.

But despite the statistically higher risk, Dr. Sampath Prahalad, associate professor of pediatrics and human genetics at the Emory University School of Medicine, said cancer in children with JIA is rare.

“The risk is very low, and it's more common for children with JIA to not get cancer,” he said. The study included only 7,812 children with JIA, and nationwide, there are about 300,000. Prahalad was not involved with the research.

Beukelman said there are a number of possible explanations for the finding, but so far, no one knows why JIA may predispose children to cancer. He stressed, however, that there was no association between cancer risk and any treatments for the condition, including the use of drugs known as tumor necrosis factor (TNF) inhibitors.

TNF inhibitors, including the brand-name drugs Enbrel and Humira, are considered by doctors to be revolutionizing treatments that can sometimes stop rheumatoid arthritis in its tracks.

But there have been a number of case reports linking the use of TNF inhibitors to an increased cancer risk in children, prompting the Food and Drug Administration (FDA) to add a black box warning to these drugs in 2009. A black box warning is the strongest warning used by the FDA and indicates a drug has potentially life-threatening effects.

“The initial concern about TNF inhibitors may have been overstated, since some of the risk likely comes from the disease itself,” Beukelman said.

Beukelman explained that when the FDA made its decision to include black box warnings on TNF inhibitors, the only data available compared children with JIA who took these drugs with healthy children.

“When we're evaluating the safety of these drugs, it's important to make comparisons to other children with the disease who didn't get the drugs and not comparisons to children in the general population,” he said.

Does Disease Itself Predispose to Cancer?

Previous studies have found a link between elevated cancer risk and certain inflammatory conditions in adults.

“There are studies that show that in adults with rheumatoid arthritis, the more severe the disease, the higher the disease activity, so the more likely the patient is to develop malignancy,” Beukelman said.

It could be, he explained, that because diseases like JIA attack the body's own immune system, the body isn't able to mount defenses against invading cancer cells.

Another possibility is that the persistent inflammation characteristic of JIA could lead to cancers, particularly in the blood cells, he said.

See the rest here:
Does Arthritis Raise Kids' Cancer Risk?

U.S. begins stem cell trial for hearing loss

Monday, February 13th, 2012

WASHINGTON — U.S. researchers have begun a groundbreaking trial to test the potential of umbilical cord blood transplants, a kind of stem cell therapy, to treat and possibly reverse hearing loss in infants.

The phase I trial follows promising studies on mice showing that such transplants were able to rebuild the structures of the inner ear, and some anecdotal evidence from humans, sparking hope of a cure for some forms of deafness.

One of those people is two-year-old Finn McGrath, who suffered brain damage after being deprived of oxygen during a prolonged and complicated delivery, according to his mother, Laura.

“His doctors told us he was at high risk for cerebral palsy, vision issues, hearing problems and mental retardation,” she said in an interview with AFP.

Finn’s early days were an all-out struggle to survive, so for his parents, learning that he had failed his hearing tests and had damaged hair cells — the sensory receptors in the inner ear that pick up sounds — was almost an afterthought.

He had organ failure, breathing problems, and his cerebral palsy left him unable to roll, crawl or walk, hold his head up, talk or eat.

As his parents searched for ways to help him, they came upon stories online that told of studies using cord blood to help children with cerebral palsy and other disorders.

Prior to his birth, the McGraths had arranged to privately bank his umbilical cord blood, a procedure that costs around $2,000 plus storage fees, and remains controversial among pediatricians.

Private companies such as the Cord Blood Registry, which is funding the Texas study on hearing loss, urge expecting parents to bank their umbilical cord blood and reserve it for personal use as a way to protect their family.

That advice runs counter to the guidelines issues by the American Academy of Pediatrics in 2007, which calls such claims “unsubstantiated” and says banking for personal or family use “should be discouraged” but is “encouraged” if it is to be stored in a bank for public use.

Since Finn’s parents had already banked his, they enrolled him in cord blood trial for cerebral palsy in North Carolina and he received his first transplant in November 2009 when he was about seven weeks old.

A second transfusion followed and by May, his parents began to notice a change.

Nighttime noises, like an alarm on his food pump or the sound of ripping medical tape, would suddenly startle him awake, his mother recalled.

“He started vocalizing sounds and we could tell that he was anticipating things that we would say. Like, if he had heard a story a number of times or a song, he would smile like he recognized the song or the story.”

Finn had a third infusion in September 2010, when he was one year old. Four months later, an otoacoustic emissions test (OAE), which plays a sound and picks up vibrations in the cochlea and hair cells, came back normal.

The early hearing tests that showed hearing loss were not exactly the same as the later tests that came back normal, so McGrath is cautious about comparing them directly, but she believes the cord blood transfusions may have helped.

“All I can tell you is anecdotally he was not able to hear for probably the first three or four months of his life, and then when he was about six to eight months old, he started hearing.”

The hearing trial in Texas aims to take a first step in testing the safety, and later the efficacy, of transfusing cord blood in children age six weeks to 18 months who have sustained post-birth sensorineural hearing loss.

Some reasons that children lose their hearing at or after birth may include oxygen deprivation, head injury, infection, strong doses of antibiotics or loud noises.

Sensorineural hearing loss affects approximately six per 1,000 children, and there is no available medical treatment. Hearing aids or cochlear implants are typically offered to boost the ability of the damaged tissues.

“Stem cell therapy may potentially repair the damaged structures of the inner ear and restore normal hearing,” lead investigator Samer Fakhri told AFP.

“We are at the initial stages of this process and the results are looking promising,” Fakhri added.

Research using stem cells in cord blood, known as hematopoietic cells, is already under way on some types of brain injury, cerebral palsy, juvenile diabetes, kidney and lung disease, he said.

The new study at Memorial Hermann-Texas Medical Center is being funded by the Cord Blood Registry, and those eligible must have already banked their own umbilical cord blood with CBR.

But to Stephen Epstein, an otolaryngologist in Maryland, that does not pose a conflict of interest, because separate medical institutions in Texas and Georgia are conducting the Food and Drug Administration-approved research.

“If both of them can reproduce the same results then I would say it has some validity to it,” said Epstein, who is not involved in the study.

“This is certainly a welcome, acceptable experiment, but it should be looked at with caution and time will tell.”

One patient is already enrolled and the study, which runs for one year, has room for nine more.

While Finn McGrath still faces many challenges due to his cerebral palsy, his mother is grateful for the things he can do.

“I don’t know how much worse off he would have been without the stem cell transfusion,” McGrath said, pointing to his normal cognition, lack of seizures, good hearing and vision.

“We remain hopeful that he will continue to improve.”

© Copyright (c) AFP

Link:
U.S. begins stem cell trial for hearing loss

Will bill make food safer or be a form of control?

Monday, February 13th, 2012

DANYA LEVY

Warrantless searches of houses and marae for food and seeds, even with guns, are coming to New Zealand soon thanks to the Food Bill unless you do something, says the petition on the social-networking website Facebook.

The campaign by the New Zealand Food Bill Action Group aims to collect 50,000 signatures and is just 10,000 short.

It claims the Food Bill, which is poised to return to Parliament after being considered by the primary production select committee, will take away New Zealanders' rights to grow food when and how they please, and remove access to natural medicine and non-genetically modified seeds and vegetables.

“It must be stopped,” says the group.

Food Safety Minister Kate Wilkinson says it's a scaremongering campaign.

“It's not particularly useful, but it's an opportunity for us to get the right message across. There is a lot of misinformation.”

The National-led Government has been trying to counter that by providing information to its electorate MPs who are fielding questions from concerned voters.

It won't be the end of farmers' markets, she assures. Those selling fruit and vegetables directly to consumers don't have to be registered and will not incur any costs, but will be “directed” to a food handler pamphlet. Those holding sausage sizzles, community functions and other fundraising events will also need a pamphlet.

But those selling bread and jam at the markets will need a level 2 certificate under a proposed classification system and will have to be registered annually and undergo kitchens inspections every few years.

The Government argues because it's currently illegal to sell goods to the public that are made in a home kitchen, the bill “legitimises this Kiwi tradition” and ensures the food being made is safe.

Ms Wilkinson admits the bill has inadvertently captured seeds for propagation by classifying all seeds as food. “We have said we will change that.”

However, NZ First says other products could also be inadvertently captured. Depending on how you read the bill, that could even include water, its primary production spokesman Richard Prosser says.

“That would never stand the test, but it needs to have greater clarification around it.”

NZ First is also concerned about the powers food safety inspectors will be given and who those inspectors will be.

“At the moment, we are looking at any person, who could be Joe Blow off the street, effectively being given the powers of a sworn police officer.

“If you are going to have people searching premises and breaking in, it is much better if they are trained and aware of the legal ramifications.”

The minister says inspectors will have no additional powers than they do now and will be open to prosecution should they act unlawfully.

“We don't have provisions for arming them and they still have to act in good faith and reasonably.”

Mr Prosser says a great deal of ambiguity remains around some of the legislation's provisions.

However, Ms Wilkinson says that's the nature of the 366-page bill: it's flexible so it doesn't have to be amended if something is inadvertently captured.

“That is the balance we have tried to get. You can't have certainty and flexibility.”

Former Green MP and long-time food safety advocate Sue Kedgley says the bill targets the wrong issues.

“If the Government was serious about trying to reduce food poisoning in New Zealand, they would be ignoring the local growers and focusing on imported food, slaughter houses and cleaning up factory farms,” she says.

Food poisoning rates in New Zealand are very high, with campylobacter levels some of the highest in the world.

“But they tend to come from chicken and custard squares. They are not coming from fresh fruit and vegetables.”

While most countries randomly test 5 to 10 per cent of imported produce, New Zealand tests only 0.25 per cent, she says.

“We import food from countries with very poor food-safety systems, if any.”

Organic New Zealand editor Philippa Jamieson says her magazine is about to publish a story saying while the bill may reduce micro-organisms, such as listeria, it will not reduce long-term food-related illnesses, because it will not cut the salt, sugar, fat, additives and colourings in food.

She also says annual registration is a concern for small producers. “It may be more bureaucratic or expensive and put some small producers off. I don't know if it will put someone out of business, but it might be another hurdle.”

The Greens have been calling for an exemption for small growers, something the Government has dismissed.

Small-scale producers – such as those producing food at home, selling directly to consumers or not employing anyone else – will be able to apply to the Agriculture and Forestry Ministry for an exemption from the classification system and its associated registration and inspection costs.

The ministry will monitor the types of exemption requests and if there is enough of the same type, it can exempt a whole sector.

However, Ms Kedgley questions that decision from a Government which advocates getting rid of red tape and unnecessary regulation.

She agrees it will deter people from starting or continuing small-scale businesses and suggests it will lead to a “black market in fruit and vegetables”.

“I know people who sell some of their surplus produce at various times of the year to local vegetable shops.

“They are all saying either they are going to completely stop doing it because they don't want to be caught up in this whole thing and have their properties audited and do these national programmes, or they are just going to sell it illegally.”

Labour's food safety spokesman, Damien O'Connor, says the Greens want to “have their cake and eat it too”.

“If we are going to give widespread exemptions and trust people, we are going to be putting ourselves at risk if some scoundrel comes in and abuses the system.”

He agrees there is a lot of misinformation about the bill. “It's important the Government get out and clarify that for people, before it pushes this bill through.”

Those selling food for charity less than 20 times a year will not have to register or incur costs, but Mr O'Connor says people have been raising questions with him about the exchange of food.

“Someone asked about pot-luck dinners. If they have one a week, does that mean they are going to be subject to the regulation?”

ONLINE, some of the concern about the Food Bill is based on fear over the reach of the Codex Alimentarius, the food standards and guidelines for food trade created by the World Health Organisation and the Food and Agriculture Organisation (FAO) of the United Nations.

New Zealand has been a member since FAO was formed in 1963 and there are 185 member nations.

Freelance journalist Guy Ralls, who is an experienced organic farmer, wants the entire Food Bill scrapped, saying it “takes away the right to grow food and changes it into a privilege”.

He says the FAO is lobbied by and supported by multi-national corporations in the bio-technology, agribusiness and pharmaceutical industries.

He claims the Codex is pushing the Food Bill.

“The way that Codex food guidelines will be enforced in this country if the Food Bill is passed is through the regulations which are applied to registered food businesses.

“The Food Bill is New Zealand's implementation of the Codex Alimentarius.”

Other countries are also being forced to implement the Codex, which is why food legislation is also being passed in the United States, India and throughout Europe, he says.

However, a spokesman for Ms Wilkinson says under the Codex, countries retain their sovereign right to decide how food safety and consumer health is regulated domestically.

The Food Bill is nothing to do with the Codex or multi-national companies such as Monsanto trying to get more genetically modified food into New Zealand, he says.

Work on the bill began in 2003, when the then Labour government decided it was time to review the 1981 Food Act.

The following year, the domestic food review was launched, which involved two years of consultation. In 2007, officials began to draft the bill, which wasn't ready to be introduced to Parliament until 2010, showing the complex nature of the legislation.

THE Greens want the bill to introduce a country-of-origin labelling system, which the party has been seeking for years.

However, that has been ruled out by Ms Wilkinson, who says it is a consumer choice issue, not one of food safety.

The Greens' primary production spokesman, Steffan Browning, says that is disappointing.

“She's just taking the Food Safety Authority's line, which is quite unfortunate. She is becoming a bit of a `yes minister'.”

Country-of-origin labelling is a food safety issue, because consumers have a right to avoid produce from countries which use certain pesticides and insecticides, and have events such as the nuclear meltdown at the Fukushima plant in Japan, he maintains.

“We have that around sugars and fats and other things on product labels.

“Why shouldn't we be able to make further choice around food safety through country-of-origin labelling?”

New Zealand's major trading partners, the United States and Australia, have country-of-origin labelling.

Consecutive governments have maintained such labelling is a barrier to trade and point to the export of minced beef to the US for hamburger meat, which they claim could be harmed because American consumers prefer locally produced goods.

However, Mr Browning says there is something wrong with New Zealand's trade if it has to be “so sneaky”.

The Greens are also concerned genetic modification has been removed from the bill and warn it will be a “sticking point”.

“We do see genetic modification as a relatively young technology that is showing up to have negative health effects.

“Research that is done independently is increasingly finding some concerning changes to the nature of the crop that is produced.”

While there are labelling laws for genetically modified produce, Mr Browning says they are not enforced or even monitored.

The Food Bill introduces a level of intrusion into New Zealand's food supply, he says.

“Some people say this bill is about setting us up for the Trans Pacific Partnership (free trade agreement).

“The Greens are likely to be calling for ring-fencing of our domestic food supply so that our provisions around food are still sovereign to New Zealand.”

Labour and the Greens are waiting to see what changes are made to the bill when it comes back to Parliament before deciding whether they will support it further.

The Greens and NZ First want the bill sent back to the select committee for further consideration – but that has been ruled out by the minister. The Maori Party, UnitedFuture and ACT are yet to decide whether they will back the bill.

NZ First will oppose the bill in its present form and Hone Harawira says he will oppose it.

That means the Government could find itself two votes short of the 61-vote majority it needs to make the bill law unless it can ease the concerns of political parties and the public.

THE FOOD BILL

WHO IT APPLIES TO:

Those selling or trading food for commercial purposes.

Food such as bread and jam made in a home kitchen and sold to the public ( illegal under current law).

Commercial growers who supply supermarkets.

Small growers who sell most of their stock direct to customers but occasionally sell or trade excess stock to shops or restaurants.

Businesses making higher-risk foods such as meat or dairy products (who are required to have food safety plans in place under current law).

Businesses selling jams, pickles and breads.

WHO IT DOESN'T APPLY TO:

Food grown at home for family consumption.

Food given away.

Food swapped for other food with friends.

Cakes, jams or other foods sold for charity up to 20 times a year.

– © Fairfax NZ News

Continued here:
Will bill make food safer or be a form of control?

Foods to Avoid for Keeping Kidneys Healthy – Video

Friday, February 10th, 2012


03-08-2011 05:51 Foods Good for Your Kidneys – as part of the expert series by GeoBeats. The five foods that you want to avoid to prevent kidney disease are really important because kidney disease is really prominent in the US and more and more people are being diagnosed with kidney disease. The two major causes are: diabetes is the number one cause of kidney disease, and then high blood pressure, hypertension. So, for the high blood sugar, you want to make sure that you control it. If you are a diabetic, you have to get that under control. If you are genetically dispositioned for it, or you are pre-diabetic, you really want to get on top of it and stay ahead of the game. And the easiest way to do that is to avoid refined carbohydrates. And when I say refined, I mean things like white flour, white bread, rice, white pastas. Controlling these in the diet really helps to make a big difference in reducing the blood sugar levels. The other one is soda. There has been a lot of recent research that shows as little as two sodas a day can increase kidney disease by 30%, and that is pretty significant. Okay, so remember the second cause of kidney disease is hypertension/ high blood pressure. Most sodium does not come from the salt shaker that you put on your food. It is sort of hidden. And a big source of that is fast foods. Fast foods are loaded with sodium. They act as a preservative, and a flavor enhancer, so that is why they are in there. The other one is frozen dinners. And I am not talking

See the original post here:
Foods to Avoid for Keeping Kidneys Healthy – Video

US begins stem cell trial for hearing loss

Wednesday, February 8th, 2012

The phase I trial follows promising studies on mice showing that such transplants were able to rebuild the structures of the inner ear, and some anecdotal evidence from humans, sparking hope of a cure for some forms of deafness.

One of those people is two-year-old Finn McGrath, who suffered brain damage after being deprived of oxygen during a prolonged and complicated delivery, according to his mother, Laura.

“His doctors told us he was at high risk for cerebral palsy, vision issues, hearing problems and mental retardation,” she said in an interview with AFP.

Finn's early days were an all-out struggle to survive, so for his parents, learning that he had failed his hearing tests and had damaged hair cells — the sensory receptors in the inner ear that pick up sounds — was almost an afterthought.

He had organ failure, breathing problems, and his cerebral palsy left him unable to roll, crawl or walk, hold his head up, talk or eat.

As his parents searched for ways to help him, they came upon stories online that told of studies using cord blood to help children with cerebral palsy and other disorders.

Prior to his birth, the McGraths had arranged to privately bank his umbilical cord blood, a procedure that costs around $2,000 plus storage fees, and remains controversial among pediatricians.

Private companies such as the Cord Blood Registry, which is funding the Texas study on hearing loss, urge expecting parents to bank their umbilical cord blood and reserve it for personal use as a way to protect their family.

That advice runs counter to the guidelines issues by the American Academy of Pediatrics in 2007, which calls such claims “unsubstantiated” and says banking for personal or family use “should be discouraged” but is “encouraged” if it is to be stored in a bank for public use.

Since Finn's parents had already banked his, they enrolled him in cord blood trial for cerebral palsy in North Carolina and he received his first transplant in November 2009 when he was about seven weeks old.

A second transfusion followed and by May, his parents began to notice a change.

Nighttime noises, like an alarm on his food pump or the sound of ripping medical tape, would suddenly startle him awake, his mother recalled.

“He started vocalizing sounds and we could tell that he was anticipating things that we would say. Like, if he had heard a story a number of times or a song, he would smile like he recognized the song or the story.”

Finn had a third infusion in September 2010, when he was one year old. Four months later, an otoacoustic emissions test (OAE), which plays a sound and picks up vibrations in the cochlea and hair cells, came back normal.

The early hearing tests that showed hearing loss were not exactly the same as the later tests that came back normal, so McGrath is cautious about comparing them directly, but she believes the cord blood transfusions may have helped.

“All I can tell you is anecdotally he was not able to hear for probably the first three or four months of his life, and then when he was about six to eight months old, he started hearing.”

The hearing trial in Texas aims to take a first step in testing the safety, and later the efficacy, of transfusing cord blood in children age six weeks to 18 months who have sustained post-birth sensorineural hearing loss.

Some reasons that children lose their hearing at or after birth may include oxygen deprivation, head injury, infection, strong doses of antibiotics or loud noises.

Sensorineural hearing loss affects approximately six per 1,000 children, and there is no available medical treatment. Hearing aids or cochlear implants are typically offered to boost the ability of the damaged tissues.

“Stem cell therapy may potentially repair the damaged structures of the inner ear and restore normal hearing,” lead investigator Sami Fakhri told AFP.

“We are at the initial stages of this process and the results are looking promising,” Fakhri added.

Research using stem cells in cord blood, known as hematopoietic cells, is already under way on some types of brain injury, cerebral palsy, juvenile diabetes, kidney and lung disease, he said.

The new study at Memorial Hermann-Texas Medical Center is being funded by the Cord Blood Registry, a private bank, and those eligible must have already banked their own umbilical cord blood with CBR.

But to Stephen Epstein, an otolaryngologist in Maryland, that does not pose a conflict of interest, because separate medical institutions in Texas and Georgia are conducting the Food and Drug Administration-approved research.

“If both of them can reproduce the same results then I would say it has some validity to it,” said Epstein, who is not involved in the study.

“This is certainly a welcome, acceptable experiment, but it should be looked at with caution and time will tell.”

One patient is already enrolled and the study, which runs for one year, has room for nine more.

While Finn McGrath still faces many challenges due to his cerebral palsy, his mother is grateful for the things he can do.

“I don't know how much worse off he would have been without the stem cell transfusion,” McGrath said, pointing to his normal cognition, lack of seizures, good hearing and vision.

“We remain hopeful that he will continue to improve.”

(c) 2012 AFP

Read the rest here:
US begins stem cell trial for hearing loss

Eyesight Improves (raw) – Video

Tuesday, February 7th, 2012


08-11-2011 11:42 I’ve been in North Carolina ministering with Coelho (www.youtube.com and Pete Cabrera (www.youtube.com During the first night in town, we were able to minister to a church congregation. This is a testimony of he wife of the pastor of the church getting her vision restored significantly. Later that night, when we were just hanging out and eating, I asked her how bad her vision was before and she said it was -3.25 (about 20/150). She said that she used to not be able to distinguish the food in front of her without her glasses, but that night, she was able to! — www.iamaspirit.org

Read more:
Eyesight Improves (raw) – Video

Thousands of Canadians Stretch Their Philanthropic Muscles to Raise Funds for Critical Arthritis Research

Tuesday, February 7th, 2012

TORONTO, ONTARIO–(Marketwire -02/06/12)- Editor's Note: There are 3 videos associated with this release.

On Sunday March 4, 2012 thousands of Canadians will do their best downward dog pose at Power of Movement 2012, Canada's largest yoga fundraiser in support of arthritis and autoimmune disease research. Since its inception in 2005, Power of Movement has raised over $1 million for critical arthritis research and engaged thousands of Canadians in a celebration of movement.

Thousands of Canadians will 'spread their karma' and do yoga together!

On March 4th, the Power of Movement will take place in 19 locations from coast-to-coast including Vancouver, Calgary, Saskatoon, Winnipeg, Kitchener-Waterloo, Toronto, Mississauga, Oakville, Oshawa, Thunder Bay, Vaughan, Hamilton, Sarnia, Aurora, Ottawa, Montreal, and Bedford. Canadians can register to participate in a yoga mega-session and start collecting pledges through a personalized fundraising page at www.powerofmovement.ca.

Canadians who want to attend a mega-session but don't live in a designated region can still participate through the Virtual Challenge which is assisted through the online yoga service of My Yoga Online, an online yoga community giving a free 30-day membership to everyone who registers for the event.

Reaching Canadians Coast to Coast

From its humble beginnings as a small grassroots initiative in a Toronto community centre almost six years ago, Power of Movement has grown to challenge Canadians in every corner of the country to take action for meaningful change in arthritis and autoimmune disease research. Funds raised will benefit arthritis and autoimmune disease research priorities through the Arthritis Research Foundation.

Quotes

“Each year we hope to exceed our fundraising goal to help the 4.6 million Canadians living with arthritis and autoimmune diseases and this year is no different,” says David Prowten, Executive Director of the Arthritis Research Foundation, the organization behind Power of Movement. “Everyone does yoga, and this is your chance to do it for a great cause. I encourage everyone to join us on March 4th in a celebration of movement to help raise money for critical research that can change people's lives.”

“I'm thrilled to be participating in the Power of Movement mega-session in Montreal for the fourth time,” says Elana Rudick, who lives with Ankylosing Spondylitis, a form of arthritis. “Yoga has helped me immensely and has had a profound effect on my physical and emotional wellbeing since being diagnosed six year ago.”

Connect with Power of Movement

Become a fan of Power of Movement on Facebook; follow us on Twitter @powerofmovement and check us out on Youtube.

Meet our Celebrity Ambassadors

David Paetkau of CTV's Flashpoint, Anthony Sedlak of the Food Network, Farah Nasser of CP24, Melissa Ramos of Sexy Food Therapy, Author Nicole Bouchard Boles, Chan Hon Goh of Goh Ballet and Beth Shaw of Yogafit.

Sponsors

Power of Movement 2012 is made possible with the support of Presenting Sponsor and global healthcare company Abbott, which has been involved with the fundraiser since 2007, as well as National Post, My Yoga Online, Amgen/Pfizer, Joe Fresh, and a host of other sponsors.

About the Arthritis Research Foundation

The Arthritis Research Foundation raises funds and awareness for the most comprehensive, collaborative, and specialized arthritis research centre in Canada. It is housed at University Health Network (UHN), which comprises Toronto General, Toronto Western, Princess Margaret Hospitals, Mount Sinai Hospital and Toronto Rehabilitation Institute. The Arthritis Research Foundation is dedicated to research in arthritis and related autoimmune diseases, musculoskeletal health, and advancements in orthopaedic surgery.

To view the first video associated with this press release, please visit the following link: http://www.youtube.com/watch?v=k4qK6xNEz74.

To view the second video associated with this press release, please visit the following link: http://www.youtube.com/watch?v=mM8m6M27Jyo.

To view the third video associated with this press release, please visit the following link: http://www.youtube.com/watch?v=7cW4jzp2b9Y.

See the original post here:
Thousands of Canadians Stretch Their Philanthropic Muscles to Raise Funds for Critical Arthritis Research

Veterinary Medical Colleges Cope With State Cuts but Feel the Pain

Monday, February 6th, 2012

To: EDUCATION AND NATIONAL EDITORS

WASHINGTON, Feb. 6, 2012 /PRNewswire-USNewswire/ — The nation's 28 schools and colleges of veterinary medicine (CVMs) are feeling the painful effects of $104 million worth of state appropriation cuts over the past two years. At the same time, CVMs have managed to stay on course through a combination of belt tightening and tuition increases that only partially make up for the cuts. These findings are the result of a recent economic study by the Association of American Veterinary Medical Colleges (AAVMC), which — along with the American Veterinary Medical Association (AVMA) — is examining the economic issues that affect veterinary medical education and veterinary medicine as a whole.

In his recent State of the Union speech and subsequently, President Obama warned colleges that schools can't just “jack up tuition every single year” and simply expect people to pay it, adding that, “If you can't stop tuition from going up, the funding you get from taxpayers every year will go down.” Obama is targeting Perkins loans, work-study jobs, and Supplemental Educational Opportunity Grants.

In response, CVM deans say that they agree with the need to do something about escalating tuition in higher education, which burdens graduates across all professions with often-hefty payments at a time when they are trying to get their careers off the ground. Deans often have only limited, shared decision-making power over tuition rates. For example, in the public sphere, states approve the tuition increases that universities propose and governing boards implement. In simplest terms, students are paying more because the state is paying far less.

The AAVMC is working to publicize and increase loan forgiveness or loan restructuring payment options. Deans point out that they are working hard to reduce the overall cost to educate students through improved campus efficiencies and that, despite state cuts, their tuition increases are less than the national average. For example, according to the College Board, average undergraduate tuition at state colleges rose 8.3 percent this year, and, according to the Association of American Medical Colleges, resident medical school tuition rose 7.7 percent, while the average tuition at state CVMs rose 6.6 percent.

According to a recent AAVMC survey, the belt tightening comes at a cost. Of the 28 deans, 71.4 percent reported that state cuts are reducing their schools' ability to hire and maintain faculty; 53.5 percent reported that the cuts are affecting their ability to maintain some academic course offerings for students; and 50 percent reported that cuts are interfering with efforts to provide extension and outreach services.

In 2011, the AAVMC released Roadmap for Veterinary Medical Education in the 21st Century: Responsive, Collaborative, Flexible, a report found at www.aavmc.org/roadmap that was compiled by the North American Veterinary Medical Education Consortium (NAVMEC). As reported in that publication, many CVMs have laid off staff members, reduced the number of faculty members, and eliminated programs.

“What is most worrisome is that CVMs report that they have been unable to fill a significant number of faculty positions,” said Dr. Gerhardt Schurig, AAVMC president and dean of the Virginia-Maryland Regional College of Veterinary Medicine. “Some hopefully temporary cost-cutting measures that can help are to hire part-time or adjunct faculty or slightly increase the student-to-faculty ratio, but we don't want to do that to such a degree that we dilute the quality of the veterinary medical education experience, and we particularly need to manage the size of clinical medical rotations in order to provide a hands-on, individualized educational experience.”

Many CVMs are part of schools established through passage of the 1862 Morrill Land-Grant Act, which stressed “agriculture and mechanic arts,” with most financial support coming from state departments of agriculture. “With time, and the shift of the North American population to urban settings, [direct] financial support to land-grant universities has declined sharply, in stark contrast to what has been provided to schools of human medicine, dentistry, and nursing,” says the NAVMEC report. The last major influx of federal funds to veterinary schools came in the late 1970s and early 1980s.

Today, agriculture and farm animal care is just one of the multiple roles veterinarians play, and a shift toward companion animal practice, the human-animal bond, and a “one health” approach has occurred. “One health” focuses on the intersection of human, animal, and eco-system health. “Veterinarians are the only professionals educated in a comparative, cross-species approach to diagnostics, epidemiology, and preventive medicine, which is important for a comprehensive, global, 'one health' direction. As this new direction grows, the demand for veterinarians will grow. It will only take a major outbreak of a disease common to humans and animals, bioterrorism attack, or a compromise of the food system infrastructure to dramatically spike an immediate need for additional veterinarians,” Schurig said.

From a financial perspective, “The focus of CVMs shifted and many traditional federal revenue streams dried up without any major new funding to support the important work that CVMs do,” Schurig said. “Now, on top of that, we're coping with a drastic reduction in state financial support.”

“In light of recent trends, CVMs, the AAVMC, and the AVMA need to pursue the NAVMEC report's recommended approaches now more than ever,” said Dr. Bennie Osburn, interim executive director of the AAVMC. The report recommends that colleges of veterinary medicine provide a cost-effective, quality education with a “one health” approach where CVMs share educational resources and partner with the AVMA and other stakeholders nationally, internationally, and locally, to develop economically viable approaches to veterinary medical education.

The Association of American Veterinary Medical Colleges (AAVMC) is a nonprofit membership organization working to protect and improve the health and welfare of animals, people, and the environment by advancing academic veterinary medicine. Its members include all 33 veterinary medical colleges in the United States and Canada, nine departments of veterinary science, eight departments of comparative medicine, three veterinary medical education institutions, nine international colleges of veterinary medicine, and five affiliate international colleges of veterinary medicine. On the Web: http://www.aavmc.org

SOURCE Association of American Veterinary Medical Colleges

-0-

The rest is here:
Veterinary Medical Colleges Cope With State Cuts but Feel the Pain

OU nanoparticle research may fight cancer cells

Monday, February 6th, 2012

New research using nanoparticles is on the frontline on the war against cancer

OU researchers are hoping extremely tiny particles outfitted with medicine can be used to discover and fight cancer more effectively.

Dr. Rajagopal Ramesh, who has worked at the OU Health and Sciences Center for the past year and a half as a researcher, is creating and testing nanoparticles on lung cancer cells to discover new ways to fight cancer.

AT A GLANCE

Nanoparticles

The particles Dr. Rajagopal Ramesh and the OU Health Sciences Center researchers are working with are 18 nanometers in size. A nanometer is one-billionth of a meter.

The nanoparticles, which are billionths of a meter in size, are composed of an iron core and a gold layer covered in Cetuximab, a U.S. Food and Drug Administration approved antibody, Ramesh said. The particles are introduced into the body intravenously, according to a peer-reviewed research article in the science journal PLoS ONE.

The particles’ size allows them to maneuver through the body’s smallest blood vessels with greater ease than traditional drugs, the iron core allows the use of MR, and the golden surface helps medicine adhere to the particle while having optical properties that illuminate under laser light, Ramesh said.

Varying on the density of the gold under laser light, the particles will illuminate in shades of blue, red or green. For example, if there was a tumor infested with those particles, a doctor could shine a laser over the surface and identify the edges of a tumor, Ramesh said. Without this technology, doctors could surgically extract a portion of a tumor but leave superfluous cancer cells remaining around the edge.

The initial purpose of the research was to curb the collateral damage done by chemotherapy to healthy cells and to increase the duration of drug circulation in the body, Ramesh said.

When the size of the capsule for this therapy was brought down to the nano level, it became easier for the drug to pass through the blood vessels and have made a greate impact on tumors, Ramesh said.

The materials used for these drugs can come from a wide range of substances. Ramesh and his team have been using an iron core in the particles so they will show up using MRI.

Traditionally, to assess the effectiveness of a treatment, patients will prepare for days before undergoing an MRI, which is costly and time consuming, Ramesh said. That time can be better spent, and a few days are often the difference between life and death in cancer treatment, Ramesh said. The nanoparticles’ iron core makes it possible to perform an MRI without the days of preparation to immediately establish a treatment’s effectiveness, Ramesh said.

“What we are coming into now is the age of personalized medicine,” Ramesh said. “All cancers are unique. One person’s lung cancer is different than another person’s lung cancer.”

The gold serves other benefits as well. When gold is hit with light, it generates heat. By raising the temperature of the particles, the cancer can be burned away. Also, the golden surface is conducive for attaching antibodies, which help fight the cancer, Ramesh said. The Cetuximab antibody essentially starves cancer cells by not allowing them to receive the signals they need to grow.

The research is promising, but don’t expect the procedure to be on the market anytime soon, Ramesh said. There are many more steps to take and more research to be done before this can move to human trials, and after that, there is the hurdle of getting approval from the Food and Drug Administration.

View post:
OU nanoparticle research may fight cancer cells

ddf0dr1v3r2′s Advices for Protecting Yourself against Cancer

Saturday, February 4th, 2012


15-01-2012 06:04 * The BEST Way to protect against cancer and very bad diseases is NATURE. * PREVENTION and BEING IN NATURE HARMONY are The First Things to do. * Eat ENOUGH MEAT and PLENTY FRUITS + VEGETABLES for Being Healthy. * But … what’s The Point with Cancer? Cancer is A CELULAR DISEASE. * For example, if you eat TOO MANY RAFINATED OILS (bad substance for cells which destroys by making them to auto-modify to be abel to assimilate it) That is NoT A Good Prevention. * So AVOIDING BAD FOODS and DRINKS is A Way To Prevent/Avoid Cancer. * Another Way For Preventing/Avoiding Cancer is by CONSUMING GOOD FOOD and DRINKS. There are Antioxidant Substances in foods and drinks which are BEST “TOOLS” TO FIGHT AGAINST/TO PREVENT CANCER. * Examples of Antioxidant Foods and Drinks : Sunflower Seeds

Originally posted here:
ddf0dr1v3r2′s Advices for Protecting Yourself against Cancer

Celexa or Lexapro – Video

Saturday, February 4th, 2012


22-11-2011 12:55 Order Lexapro: pillsrx24.com Order Celexa: pillsrx24.com Celexa or Lexapro Buy LEXAPRO now from selected reliable online pharmacies! Enjoy the Low Prices, Fast Trackable Delivery and Secure Online Processing! Lexapro (Escitalopram) 20 mg I saw a patient in clinic today who was 6 weeks post weight loss surgery from her Gastric Bypass. She was very well and varying her food choices. Supporting Actress, Drama Series: Cherry Jones, “24,” Fox. Sign up for Intel Software Techdays Our range of medical services include cardiac care and heart disease treatment. Occupational therapy, Ophthalmology (eye care), Optometry (eye services). celexa or lexapro discussion is celexa or lexapro bad for anxiety celexa or lexapro problems celexa or lexapro dosage is celexa or lexapro better for phobia is celexa or lexapro better for stress celexa or lexapro and weight gain which is great celexa or lexapro celexa better than lexapro or zoloft celexa or lexapro side effects although which is better celexa or lexapro antidepressant celexa or lexapro escitalopram celexa or lexapro celexa versus lexapro or zoloft which is better celexa or lexapro they or lexapro side effects celexa since celexa or lexapro forum is celexa or lexapro better for depression celexa or lexapro or paxil celexa or lexapro benefits celexa or lexapro or zoloft is celexa or lexapro better for anxiety celexa or lexapro difference which is better celexa or lexapro depression is celexa or lexapro faster for anxiety

Read more here:
Celexa or Lexapro – Video

DaVita Promotes Super Bowl XLVI Finger Foods for the Kidney Diet

Thursday, February 2nd, 2012

DENVER–(BUSINESS WIRE)– DaVita Inc. (NYSE: DVA – News), a leading provider of kidney care services that is committed to improving the quality of life for those diagnosed with chronic kidney disease (CKD), offers kidney patients a chance to enjoy delicious Super Bowl® Sunday treats with kidney-friendly recipes. Recipes are available online on DaVita’s special occasion diet and nutrition page.

While celebrations and party food temptations can be difficult for anyone following a special diet, they pose an even greater challenge for those with CKD. CKD patients must modify their protein, phosphorus, potassium, sodium and fluid intake, which can be complicated to monitor during snack-filled events such as Super Bowl parties.

“Super Bowl Sunday is very much about the food,” said DaVita Dietitian Sara Colman. “These Super Bowl recipes are designed to meet the unique dietary and nutritional needs of CKD patients and are tasty enough for everyone to enjoy.”

DaVita® offers kidney patients recipes that are protein-modified, low-phosphorus, low-potassium and low-sodium. Kidney-friendly football favorites include Hot Crab Dip; Pineapple, Pork and Pepper Pizza; Artichoke Relish on Pita Bread; and Honey-Maple Snack Mix.

To wash down those tasty snacks, DaVita dietitians recommend kidney-friendly beverages such as 7UP®, Sprite®, ginger ale or Barq’s® root beer. Coffee and tea are also good choices. Avoid beer, however, as it is high in phosphorus.

For a full list of Super Bowl recipes and other kidney-friendly options, visit DaVita’s Super Bowl XLVI’s recipes page on DaVita.com.

DaVita® is a registered trademark of DaVita Inc. All other trademarks are the property of their respective owners.

About DaVita

DaVita Inc., a Fortune 500® company, is a leading provider of kidney care in the United States, delivering dialysis services to patients with chronic kidney failure and end stage renal disease. DaVita strives to improve patients’ quality of life by innovating clinical care, and by offering integrated treatment plans, personalized care teams and convenient health-management services. As of September 30, 2011, DaVita operated or provided administrative services at 1,777 dialysis facilities, serving approximately 138,000 patients. DaVita supports numerous programs dedicated to creating positive, sustainable change in communities around the world. The company’s leadership development initiatives and social responsibility efforts have been recognized by Fortune, Modern Healthcare, Newsweek and WorldBlu. For more information, please visit www.davita.com.

See the rest here:
DaVita Promotes Super Bowl XLVI Finger Foods for the Kidney Diet

According to the FDA, Your Stem Cells Are Now Drugs [Fda]

Thursday, February 2nd, 2012

In recent court filings, the Food and Drug Administration has asserted that stem cells—you know, the ones our bodies produce naturally—are in fact drugs and subject to its regulatory oversight. So does that make me a controlled substance?

The bizarre controversy revolves around the FDA's attempt to regulate the Centeno-Schultz Clinic in Colorado that performs a nonsurgical stem-cell therapy called Regenexx-SD. It is designed to treat moderate to severe joint, tendon, ligament, and bone pain using only adult stem cells. Doctors draw your blood, spin it through a centrifuge, extract the stem cells and re-inject them into your damaged joints. It uses no other drugs. No drugs means no FDA oversight and that does not sit well with the administration.

The FDA has since argued that a) stem cells are drugs and b) they fall under FDA regulation because the clinic is engaging in interstate commerce. That's right, a process performed at the clinic using the patient's own bodily fluids constitutes interstate commerce because, according to the administration, out-of-state patients using Regenexx-SD would “depress the market for out-of-state drugs that are approved by FDA.”

Funny, that sounds less like the FDA protecting the health of the country's citizens and more like the FDA defending its enforcement turf. The two parties have been at odds for over four years now, so we may have a while until we know if every American has in fact become a regulatable good subject to government regulation. [ANH-USA via Slash Gear]

Image via the AP

See the rest here:
According to the FDA, Your Stem Cells Are Now Drugs [Fda]

Deepak Chopra: The Higher Health — A New Map for Prevention

Wednesday, February 1st, 2012

America's obesity epidemic isn't improving because the information about how to reverse it didn't lead to motivation. The government can jiggle the food pyramid, but that won't matter as long as Americans haven't stepped on to the pyramid in the first place.

Read the rest here:
Deepak Chopra: The Higher Health — A New Map for Prevention

Integrative Medicine: Vitamin D Can Help Turn Health Around

Monday, January 30th, 2012

By Drs. Kay Judge and Maxine Barish-Wreden  Print Article

(MCT)—The winter season is
upon us, with a lack of daylight hours, cloudy days and
temperamental weather. And so we pack on the winter pounds, get
the winter blues, and go into relative metabolic hibernation
until spring arrives. But what if we could circumvent some of
this seasonal downturn in our health?

Paying attention to our Vitamin D intake may be a way to
improve our health, and to improve a host of medical
conditions. Research has found that the following medical
conditions may be linked to Vitamin D levels:

Cancer. Improving calcium and vitamin D
nutritional status substantially reduces all-cancer risk in
postmenopausal women. This was suggested from a study in 2007
of more than 1,100 women in Nebraska, in which treatment with
Vitamin D and blood levels of Vitamin D were found to be both
linked to a reduced incidence of all cancers.

Multiple Sclerosis. A recent study performed
by the U.S. military looked at more than 250 cases of multiple
sclerosis, and found that those who had higher levels of
Vitamin D in their bloodstream were at lower risk of developing
MS.

Insulin-dependant diabetes. A study of
children born in Finland in 1966 and followed for 30 years
showed that those who had supplemental Vitamin D in their first
year had a significantly lower risk of developing
insulin-dependant diabetes, and those who had rickets (severe
vitamin D deficiency) had a much higher risk of developing
insulin dependent diabetes later in life.

Rheumatoid arthritis. Postmenopausal women
with the highest total vitamin D intakes were at significantly
lower risk of developing RA after 11 years of follow-up than
those with the lowest intakes.

Osteoporosis and Fractures. Many studies
suggest that vitamin D3 supplements of at least 800 IU/day may
be helpful in reducing bone loss and fracture rates in the
elderly.

Cognitive functioning. Vitamin D deficiency
has been linked to decreased cognitive performance in older
adults.

Depression. Low vitamin D levels have been
linked to low mood and depression, with one study showing blood
Vitamin D levels 14 percent lower in people with major and
minor depression as compared to non-depressed patients.

Despite these numerous health benefits, surprisingly, more than
half of all adults and children are deficient in Vitamin D,
according to a 2008 report in the American Journal of Clinical
Nutrition.

So what should you do in the winter to ensure that you are
getting enough Vitamin D to offset the lack of vitamin D from
sunlight exposure?

You could try to obtain Vitamin D naturally through a few
foods, including some fatty fish (mackerel, salmon, sardines),
fish liver oils and eggs from hens that have been fed vitamin
D. You also can take Vitamin D in the form of a supplement.

In 2010, the Food and Nutrition Board (FNB) of the Institute of
Medicine set a Recommended Dietary Allowance (RDA) based on the
amount of vitamin D needed for bone health. It is recommended
that most adults take 600 IU of Vitamin D, with those over 71
recommended to take 800 IU of Vitamin D in supplementation.

Those most at risk for low Vitamin D levels include people who
are older, have diabetes or kidney disease, stay indoors, are
obese or have darker skin.

Drs. Kay Judge and Maxine Barish-Wreden are medical
directors of Sutter Downtown Integrative Medicine program.

©2012 The Sacramento Bee (Sacramento, Calif.)
Distributed by MCT Information Services 

 

Copyright© 2011 RISMedia, The Leader in Real Estate
Information Systems and Real Estate News. All Rights Reserved.
This material may not be republished without permission from
RISMedia.

The rest is here:
Integrative Medicine: Vitamin D Can Help Turn Health Around

Benefits of Food Biotechnology – CommonGround – Video

Friday, January 27th, 2012


24-01-2012 10:12 Suzanne Shirborun, a farmer from northwest Iowa, talks about the safety of biotechnology and why consumers are scared of it. Biotechnology speeds up the process of producing new hybrids which farmers can use

View post:
Benefits of Food Biotechnology – CommonGround – Video





Personalized Gene Medicine | Mesenchymal Stem Cells | Stem Cell Treatment for Multiple Sclerosis | Stem Cell Treatments | Board Certified Stem Cell Doctors | Stem Cell Medicine | Personalized Stem Cells Therapy | Stem Cell Therapy TV | Individual Stem Cell Therapy | Stem Cell Therapy Updates | MD Supervised Stem Cell Therapy | IPS Stem Cell Org | IPS Stem Cell Net | Genetic Medicine | Gene Medicine | Longevity Medicine | Immortality Medicine | Nano Medicine | Gene Therapy MD | Individual Gene Therapy | Affordable Stem Cell Therapy | Affordable Stem Cells | Stem Cells Research | Stem Cell Breaking Research